Alternative Funding Programs
/
When it comes to health, there's simply no alternative to timely treatment and patient-centered care.
Read More
Sacrificing Quality for the QALY
/
Patients are more than a number. But the QALY doesn't see them that way.
Read MoreBarriers to Patient Access: Co-Pay Accumulator Adjustment Programs
/
Forgo medication or sacrifice everyday essentials? Co-pay accumulator adjustment programs force patients to make difficult decisions about their health.
Read MoreMedicare Patients Need Out-of-Pocket Caps for Prescription Drug Costs
/
Out-of-pocket costs for Medicare beneficiaries are rising. It's time for policymakers to act.
Read MoreThe Co-Pay Surprise
/
A new trend has more health insurers implementing what are known as co-pay accumulator programs, which change how patients meet their annual deductible. Insurers embrace the programs to increase their revenues and discourage the use of high-cost drugs. But, in so doing, they leave patients with a difficult choice.
Read MoreUnderstanding Specialty Tiers
/
When you pick up your monthly prescription at the pharmacy counter, you may owe a co-pay of $10 or $20. Or you may pay much, much more. Why the discrepancy?
Read MoreAccessing Breakthrough Cholesterol Treatments
/
Cardiologist Seth Baum, MD, describes a hypothetical patient with a family history of extremely high cholesterol. “He’s not the typical cholesterol patient,” Dr. Baum explains, “And the typical medications, known as ‘statins,’ don’t lower his cholesterol enough.”
Read MoreUnderstanding Value-Based Contracting
/
Innovation comes at a price, one that health insurers may hesitate to pay. While some patients reap a benefit from breakthrough drugs, others do not. So how can insurers reduce their financial risk and give patients access to the innovative prescription drugs their doctor prescribes? A new video from the Alliance for Patient Access explores one intriguing option: value-based contracting.
Read MoreClinical Pathways: When Personalized Health Care Goes Off Course
/Clinical pathways streamline care by steering patients toward predetermined treatment options in a predetermined order. Insurance companies encourage their use with high-cost conditions, particularly cancer.